Recently, it was reported that the certain miRNAs targeting the 3’UTR of the insulin signaling intermediates’ mRNA are modulated by the SFA-induced obesity and NAFLD, and that these miRNAs participate actively in the development of hepatic insulin resistance [18–20]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.